Article Information
History
- February 19, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Christian Irsara1,
- Alexander E. Egger1,
- Wolfgang Prokop1,
- Manfred Nairz2,
- Lorin Loacker1,
- Sabina Sahanic2,
- Alex Pizzini2,
- Thomas Sonnweber2,
- Barbara Holzer3,
- Wolfgang Mayer4,
- Harald Schennach4,
- Judith Loeffler-Ragg2,
- Rosa Bellmann-Weiler2,
- Boris Hartmann3,
- Ivan Tancevski2,
- Günter Weiss2,
- Christoph J. Binder5,
- Markus Anliker1,
- Andrea Griesmacher1 and
- Gregor Hoermann1,6,*
- 1Central Institute of Clinical and Chemical Laboratory Diagnostics, University Hospital of Innsbruck, Innsbruck, Austria
- 2Department of Internal Medicine II, Infectious Diseases, Pneumology, Rheumatology, Medical University of Innsbruck, Innsbruck, Austria
- 3Austrian Agency for Health and Food Safety (AGES), Department for Animal Health, Moedling, Austria
- 4Central Institute for Blood Transfusion and Immunology (ZIB), University Hospital of Innsbruck, Innsbruck, Austria
- 5Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria
- 6MLL Munich Leukemia Laboratory, Munich, Germany
- ↵* Corresponding author; email: gregor.hoermann{at}tirol-kliniken.at
Posted February 19, 2021.
Clinical validation of the quantitative Siemens SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers
